Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Q-linea AB ( (SE:QLINEA) ) has issued an announcement.
Q-linea AB’s board of directors has proposed a reverse share split and a reduction in share capital to be resolved at the annual general meeting. The reverse share split aims to consolidate 1,000 shares into 1 to stabilize the share price and adjust the number of shares, while the capital reduction seeks to align the company’s capital structure with its operational needs without affecting shareholder value.
More about Q-linea AB
Q-linea AB is a company operating in the medical technology industry, primarily focused on developing innovative diagnostic solutions. The company is listed on Nasdaq Stockholm and is known for its efforts to streamline operations and optimize its capital structure.
Average Trading Volume: 38,921,716
Current Market Cap: SEK214.4M
For a thorough assessment of QLINEA stock, go to TipRanks’ Stock Analysis page.